Why the market does not like Flurizan
Guest content from Nicolaj H. Nielsen, managing director of Biostrat. A case-study on the recent licensing-deal between Myriad and Lundbeck: […]
General Biotechnology, Guest content
Uncategorized
Advertise on Biotechblog
Reach a targeted audience with BiotechBlog. Advertising opportunities are available on BiotechBlog. BiotechBlog is syndicated by BlogBurst, which means that
General Biotechnology
Journal of Commercial Biotechnology — July 2008
The March 2008 issue of the Journal of Commercial Biotechnology is now available. This issue focuses on biotechnology marketing and
General Biotechnology
Looking for writers for book projects
Looking for writers for two book projects: 1) Convert a 102 page screenplay into a book. The topic is the
General Biotechnology
Dyadic founder regains control
After an extended struggle Mark Emalfarb, the founder of Dyadic has regained control of the firm. He was originally ousted
General Biotechnology, Guest content
Six Pitfalls to Avoid in Supplier Management
Guest content from John Avellanet, managing director and principal of Cerulean Associates: Managing suppliers is fraught with challenges. Rare is
General Biotechnology, Talks and Publications
Reminder: BIO2008 Session
For those attending BIO2008, I’ll be speaking on Friday morning: Title: Scientific Communications – Trends and Liabilities Track: Public Relations/Investor
General Biotechnology
Reminder: BIO2008 book signing
For those attending BIO2008 in San Diego this year, I’ll be signing my books in the BIO bookstore on Wednesday
General Biotechnology, Guest content
Seeing the Field
Guest content from Sandy Graham, managing partner at Sequoyah Associates: Can you “see the field” of opportunity? Have your clearly
Uncategorized
Promote your expertise
Did you know that BiotechBlog posts are syndicated to outlets such as Reuters, Biospace, San Francisco Gate, Chicago Sun-Times, and
